1型糖尿病患者的肥胖悖论
1Japanese Academy of Health and Practice, Tokyo, Japan.
Frontiers in clinical diabetes and healthcare
|October 17, 2025
概括
肥胖悖论对1型糖尿病 (T1D) 患者没有明显的好处. 体重不足和肥胖都会增加风险,尽管轻度肥胖可能会降低患有脏疾病的人的死亡率,这凸显了对身体成分分析的需求.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 临床研究 临床研究
背景情况:
- 肥胖悖论表明,患有慢性疾病的超重/肥胖患者的生存率更高.
- 它在1型糖尿病 (T1D) 中的作用尚未得到充分证实.
- 目前的研究重点是身体质量指数 (BMI) 和T1D的结果.
研究的目的:
- 审查关于BMI与T1D临床结果之间的关联的证据.
- 评估T1D中肥胖悖论的存在和性质.
- 确定BMI的局限性,并建议改进风险评估方法.
主要方法:
- 大规模队列研究和对BMI和T1D结果的元分析的综述.
- 分析BMI类别 (体重不足,正常,超重,肥胖) 与死亡率/心血管事件之间的关联.
- 考虑特定的子组,如糖尿病病或慢性病 (CKD) 患者.
主要成果:
- 大多数证据不支持T1D中较高BMI的保护作用.
- 体重不足和肥胖都与心血管事件增加和全因死亡率有关.
- 轻微升高的BMI可能与T1D患者的较低死亡率有关,这些患者患有晚期病或CKD.
结论:
- 肥胖悖论在1型糖尿病中并不总是被观察到.
- 单独的BMI不足以评估T1D的风险,因为身体组成的变化.
- 身体组成分析 (脂肪,肌肉,骨质) 对于准确的T1D风险分层至关重要,特别是在并发症的情况下.
关键词:
身体构成 身体组成身体质量指数 (BMI) 是指身体质量指数.胖胖胖的 胖胖的 胖胖的死亡率 死亡率 死亡率肥胖 肥胖 肥胖 肥胖 肥胖 肥胖 肥胖 肥胖这是骨肌肉的骨架肌肉.第1类糖尿病 1型糖尿病更多相关视频
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
71.3K
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
713
相关概念视频
Carbohydrate Metabolism
13.8K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.8K
Diabetes Mellitus: Overview and Type I Subtype
4.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.9K
Diabetes: Symptoms, Diagnosis, and Complications
2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
245
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
245
